This study was designed to determine whether there is serologic or molecular evidence of human herpesvirus 8 (HHV-8) activation in renal transplant patients, an immunocompromised population at risk for development of Kaposi's sarcoma. Indirect immunofluorescence for detection of HHV-8 serum antibody and Southern blot polymerase chain reaction (PCR) for detection of viral DNA in whole blood were used. Seroprevalence and geometric mean titer (GMT) were significantly increased in the transplant group compared with healthy adults and were comparable to those in human immunodeficiency virus ( Human herpesvirus 8 (HHV-8) is a human gamma herpesvirus that is most closely related to herpesvirus saimiri and Epstein-Barr virus (EBV). It was first detected in AIDS-associated Kaposi's sarcoma (KS) tissue and subsequently detected by polymerase chain reaction (PCR) in all clinical forms of KS (i.e., AIDS-associated, endemic African, classic Mediterranean, and iatrogenic) [1] [2] [3] [4] . However, HHV-8 is not restricted to persons with KS: Decker et al. [5] showed that lytic HHV-8 DNA is present in the peripheral blood of some adults without KS. Cell lines derived from HHV-8-positive EBV-negative body cavity-based B cell lymphomas (BCBL) have been used to develop IFAs for the detection of human serum antibodies to viral antigens [6] [7] [8] [9] [10] [11] . Assays utilizing phorbol ester-activated BCBL cells for detection of antibodies to lytic cytoplasmic antigens (enhanced IFA [EIFA]) appear to be more sensitive than assays utilizing either unstimulated whole cells or isolated nuclei for detection of antibodies to latent nuclear antigens [10] .
infected persons from southeast Texas. We also screened all seropositive renal transplant blood samples for the presence of viral DNA by PCR Southern blot to determine the prevalence of active viral replication in this population.
Materials and Methods
Patients and controls. Paired serum and EDTA-anticoagulated whole blood samples were obtained randomly from 58 adult renal transplant recipients during routine outpatient clinic visits. As controls, we used serum samples from 40 randomly selected HIV-infected adults, 14 healthy infants between the ages of 6 and 12 months, 40 healthy adult blood donors, and 6 HIV-negative patients with KS.
IFA. The cell lines BCBL-1 (NIH AIDS Repository, Bethesda, MD), K562 (American Type Culture Collection [ATCC], Rockville, MD), and P3HR1 (ATCC) were maintained in suspension culture at 37ЊC in sterile flasks containing RPMI 1640 with 10% ironsupplemented bovine calf serum (Gibco BRL, Gaithersburg, MD) in a 5% CO 2 incubator. BCBL-1 and P3HR1 cells from exponential growth phase cultures were seeded at an initial density of cells/mL to medium freshly supplemented with 20 ng/mL 5 2 ϫ 10 of TPA phorbol ester (Sigma, St. Louis). After 48 h, cells were harvested by low-speed centrifugation, resuspended in PBS, and placed into 12-well slides (Cell-Line Associates, Newfield, NJ). Slides were air-dried, fixed for 10 min in cold 100% acetone, and stored at 4ЊC in sealed desiccated boxes until use. Serum was collected within 12 h of collection and stored at Ϫ20ЊC until use. Serial 2-fold serum dilutions were prepared with sterile PBS (pH 7.2) immediately before assay. Serum dilutions (50 mL) were placed onto the cell wells for 2 h at room temperature in a covered humidified box. The slides were rinsed twice in PBS (10 min/rinse) at room temperature and immediately covered with 50 mL of a freshly prepared 1:32 dilution of fluorescein isothiocyanate-conjugated affinity-purified goat anti-human IgG (Sigma) in 0.1% Evan's blue (Sigma) in PBS. After incubation in the dark for 1 h in a covered humidified box, slides were rinsed twice (10 min/rinse) with PBS and mounted with glass coverslips using 50% glycerol and 50% PBS mounting medium. The slides were stored in the dark until blinded examination with an optical fluorescence microscope equipped with a 35-mm camera attachment (Nikon). Cases were considered HHV-8 seropositive when diffuse cytoplasmic immunofluorescence was seen in 5%-20% of the BCBL-1 cells with no cytoplasmic immunofluorescence of K562 cells.
PCR Southern blot assay. DNA was isolated from EDTAanticoagulated whole blood by commercial DNA isolation kit (Stratagene, La Jolla, CA), resuspended in 100 mM Tris-50 mM EDTA (TBE; pH 8.0), quantified by UV spectrophotometry at OD 260 (DU; Beckman Instruments, Fullerton, CA), and stored at Ϫ20ЊC until use. PCR was done with primers designed to amplify a 304-bp fragment within the open-reading frame (ORF) 26 minor capsid protein gene (GenBank accession no. KSU75698; forward primer 5 -47251-47274; reverse primer, 5 -47554-47531). Each 100-mL PCR reaction contained 50 mM KCl, 2 mM MgCl 2 , 1% Triton X-100, 2.5 U of Taq polymerase (Promega, Madison, WI), 0.2 mM dNTPs, 0.3-mm primers, and 0.5 mg of DNA (EZ Start PCR MixIn-A-Tube; Molecular Bio-Products, San Diego). Specificity of the assay was confirmed by positive results with BCBL-1 DNA and negative results with K562 and B95-8 DNA (EBV-positive). Controls run with the samples included positive control BCBL-1 DNA and a negative water blank. The cycling conditions were 95ЊC for 2 min (hot start) followed by 40 cycles at 95ЊC for 1 min, 55ЊC for 1 min, 72ЊC for 1 min, and a final 72ЊC overnight extension. After 0.8% agarose-TBE buffer gel electrophoresis and blotting to charged nylon membrane (GeneScreen Plus; NEN Research Products, Boston), specific product was hybridized with a pair of digoxigenin-labeled HHV-8 ORF 26 oligonucleotide probes (GenBank accession no. KSU75698; sequences 47287-47311 [24 mer] and 47519-47495 [25 mer], Dig Oligo Labeling Kit; Boehringer Mannheim, Indianapolis) in hybridization buffer (Dig EZ Hybe; Boehringer Mannheim) at a final concentration of 2.5 pmol/ mL. After the blot was incubated for 2 h with a 1:5000 dilution of alkaline phosphatase-conjugated anti-digoxigenin antibody (Boehringer Mannheim) and for 30 min with chemiluminescent alkaline phosphatase substrate (CSPD; Boehringer Mannheim), the bands were detected on photographic film (X-OMAT-AR; Eastman Kodak, Rochester, NY) after exposure for 20 min.
Results

IFA.
In most cases in which positive staining was seen, the staining was diffuse cytoplasmic in 5%-20% of the cells. In some cases, a coarse speckled nuclear pattern was also seen in 190% of the cells. This nuclear pattern was independent of the cytoplasmic pattern, that is, it was seen in cases with and without the cytoplasmic pattern. To avoid problems with low titer false positivity, we arbitrarily chose 1:80 as the titer below which samples were considered seronegative. However, for the purposes of calculating the geometric mean titer (GMT), all titers ≥1:20 (excluding those with nuclear fluorescence only) were included. All 6 non-HIV KS patients were seropositive with a high GMT of 1:2874. All 14 healthy infants ages 6-12 months were seronegative, even when tested at 1:10 dilution. Age 6-12 months was chosen to avoid interference from residual passively acquired maternal antibody. Of 29 healthy adults, only 2 were seropositive (7%) with a low GMT of 1:44. Of 40 HIV-positive outpatients, 29 (73%) were seropositive with an intermediate GMT of 1:172. Tests of 20 HIV-positive outpatients for anti-EBV seropositivity (P3HR1 EIFA) yielded numerous discordant BCBL-1 and P3HR1 results (data not shown). Thus, we concluded there was no correlation between HHV-8 and EBV seroprevalence. Of 58 healthy renal transplant outpatients, half (29) were seropositive with a GMT of 1:210-results similar to those for the HIV-positive group. Three renal transplant cases that were EIFA-positive were not included in the positive group, since an identical intranuclear pattern was observed with K562 cells. The increased seroprevalence seen in the renal transplant and HIV-positive populations compared with the healthy adults was statistically significant ( , x 2 distribution). Group P ! .01 data are summarized in table 1.
PCR Southern blot assay. Three (9%) of 33 renal transplant patients had detectable HHV-8 DNA in whole blood (table 2) . None of 20 healthy adult controls was positive.
Renal transplant risk factors. A careful review of the renal transplant medical records showed no obvious contribution of ethnic origin, primary disease, previous transfusion history, number of transplants, or HLA-DR5 [11, 12] positivity to increased HHV-8 seropositivity or viremic status (table 2) . However, given the small number of transplant patients examined to date, no statistically valid conclusions can be made.
Discussion
The fairly consistent demonstration of HHV-8 DNA in KS tumor tissue strongly implicates the virus in KS pathogenesis. NOTE. EIFA in bold represent antinuclear immunofluorescence only. Negative EIFA represent both those without immunoreactivity of any kind at ≥1:20 and those with K562 reactivity. Abbreviations are as follows: race-W, white; B, black; H, Hispanic; I, Native American; sex-M, male; F, female; primary disease-BN, Berger's nephropathy; GN, glomerulonephritis; GSCL, glomerulosclerosis; HTN, hypertension; SB, spina bifida; organ-K, kidney transplant; KP, kidney-pancreas transplant; no. of transfusions-NA, not applicable; PCR-neg, negative; pos, positive.
KS is a peculiar cutaneous spindle cell neoplasm seen in four distinct clinical forms: the classic form seen in elderly Mediterranean men, the endemic form of children and young adults in equatorial Africa, the epidemic form of HIV-positive adults, and the iatrogenic form seen in organ transplant patients and in persons receiving chronic immunosuppressive medication. Published HHV-8 seroprevalences in healthy and at-risk populations from a number of laboratories around the world have led to little consensus. Although differences in seroprevalences for different regions may be due to real ethnic or geographic differences, other differences may be due to the use of serologic assays that differ in sensitivity and specificity. Assays have included IFA using whole BCBL cells, whole BCBL cells activated with phorbol ester or sodium butyrate (EIFA), isolated BCBL nuclei (LANA), and ELISAs utilizing different recombinant viral proteins [6] [7] [8] [9] [10] [11] [12] . Although each assay is valid, each also has disadvantages. EIFA may be quite sensitive yet lack specificity, while LANA may be specific yet lack sensitivity, and ELISA (although highly specific and sensitive) does not detect all exposed persons if the antigen used is not universally immunodominant. However, there is no apparent cross-reactivity in the HHV-8 EIFA with anti-EBV antibody, since there was no correlation between HHV-8 and EBV titers [11] , a finding confirmed in 20 HIV-positive patients in the present study.
In the present study, we wanted to determine HHV-8 seroprevalence, HHV-8 titers, and viremic status in the renal transplant population from an ethnically diverse southeast Texas population. We compared these findings with the seroprevalence in healthy infants and in healthy and HIV-positive adults. We found that the renal transplant population had a higher (statistically significant) seroprevalence than the healthy adults: The seroprevalance was nearly as high as that in the HIVpositive population. Our limited data for the infants indicate that exposure to HHV-8 does not appear to be common in healthy infants in southeast Texas. Increased seroprevalence may indicate a higher primary infection rate occurs in a highly susceptible immunocompromised population. Transplant patients may be at increased risk of infection through the transplanted organ [13] or through blood transfusion [14] . However, an alternative interpretation should also be considered.
It is well known that iatrogenic immunosuppression leads to reactivation of latent viral infections, such as cytomegalovirus and EBV in the transplant setting, with concomitant increased antibody titer and viremia. Because serologic assays are limited by an analytic threshold below which low-titer antibody may not be detected, the increased seroprevalence may indicate not that infection rates are increased but that viral activation leads to antibody titers above detectable limits. Indeed, our data indicate that HHV-8 antibody titers of seropositive renal transplant patients are significantly higher than in healthy adults. In addition, our PCR data revealed active HHV-8 replication in 3 of 33 randomly selected renal transplant patients, but in none of 20 healthy controls, indicating that active HHV-8 replication is ongoing in some healthy renal transplant patients. Further clinical studies are in progress to determine whether PCR positivity is transient or stable and whether it places these patients at greater risk for development of KS.
